1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Complement C3 and incident hospitalization due to chronic kidney disease : a population-based cohort study
(
- Contribution to journal › Article
- 2017
-
Mark
Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study
(
- Contribution to journal › Article
- 2016
-
Mark
Increased Levels of Copeptin, a Surrogate Marker of Arginine Vasopressin, Are Associated with an Increased Risk of Chronic Kidney Disease in a General Population
(
- Contribution to journal › Article
-
Mark
Cystatin C and risk of diabetes and the metabolic syndrome - Biomarker and genotype association analyses
(
- Contribution to journal › Article
- 2015
-
Mark
Cystatin C Is Not Causally Related to Coronary Artery Disease.
(
- Contribution to journal › Article
- 2014
-
Mark
Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease.
(
- Contribution to journal › Article
- 2009
-
Mark
Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.
(
- Contribution to journal › Article